Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 9Uterine Cervical Neoplasms 7Colonic Neoplasms 6Breast Neoplasms 5Uterine Cervical Dysplasia 4Urinary Bladder Neoplasms 4Papillomavirus Infections 3Neuroblastoma 3Melanoma 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Esophageal Neoplasms 3Brain Neoplasms 3Anus Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Squamous Intraepithelial Lesions 2Rectal Neoplasms 2Precancerous Conditions 2Oropharyngeal Neoplasms 2Neoplasms 2Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Liver Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2HIV Infections 2

Interventions

enzalutamide 2sipuleucel-T 1pazopanib 1capivasertib 1Watchful Waiting 1STA 9090 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiosurgery 1Dutasteride 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenocarcinoma of the Prostate × Watchful Waiting × Clear all
NCT01795365 2018-09-28

Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer

Centre Hospitalier Universitaire Vaudois

Phase NA Terminated
60 enrolled
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡